Stock Information
Gilead Sciences Inc (GILD)
Ticker Symbol: GILD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $171,035.00 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -2.6551
Revenue (TTM): $24.50 M
Dividend Yield: 2.3744027797886%
ROE: -16.3%
Latest News
-
Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
Fri, Aug 14, 2026 12:23 PM
-
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Thu, Aug 13, 2026 9:46 PM
-
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
Thu, Aug 13, 2026 8:00 PM
-
Gilead (GILD) Stock Still Looks Cheap On Sales Despite A 127% Run
Thu, Aug 13, 2026 5:11 PM
-
Why Gilead Sciences (GILD) Is Back In The Spotlight
Thu, Aug 13, 2026 9:11 AM
-
5 Must-Read Analyst Questions From Gilead Sciences’s Q2 Earnings Call
Thu, Aug 13, 2026 4:21 AM
-
Gilead Sciences (GILD) Expands ADC Research With AI Tissue Analytics
Wed, Aug 12, 2026 6:13 PM
-
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
Wed, Aug 12, 2026 2:46 PM
-
KLA, Snowflake, Airbnb And A Health Care Stock On CNBC’s ‘Final Trades’
Wed, Aug 12, 2026 8:44 AM
-
3 Healthcare Stocks with Open Questions
Wed, Aug 12, 2026 2:53 AM
Key Financials
Financial data not available
